← All demos
CiteLLM Check · Finance

Earnings release vs 10-Q

Bioventus announced $3.2 million of net income; thirteen days later its 10-Q reported a $145.7 million loss.

What Check caught

Select one to open it in the review.Open full screen

The release's $3.2 million net income is a $145.7 million net loss in the 10-Q, after a $189.2 million goodwill impairment recorded after the release.

About this demo

Bioventus's Q3 2022 earnings release, checked line by line against its 10-Q for the same quarter. In the thirteen days between them, revenue was cut for a rebate estimate and goodwill was impaired.

How this demo was made

Both documents are real SEC filings, unchanged, and the differences between them are real, not planted. The assessments are Claude's, using CiteLLM Check; CiteLLM located every quotation and checked every figure and calculation. The review above is CiteLLM Check's own viewer, as it opens in ChatGPT and Claude.

The documents

  • CheckedBioventus Q3 2022 earnings release (Nov 8, 2022)PDFOriginal Form 8-K, Exhibit 99.1, Nov 8, 2022 (EDGAR)
  • SourceBioventus Form 10-Q for the quarter ended October 1, 2022 (filed Nov 21, 2022)PDFOriginal Form 10-Q, filed Nov 21, 2022 (EDGAR)

Run it on your documents.

Check works inside ChatGPT and Claude. Attach your PDFs, ask, and the review opens beside the chat. Draft tie-outs are part of CiteLLM Pro.

Try in ChatGPTTry in Claude or book a demo →
The request

Tie out this earnings release to the 10-Q for the same quarter.

Attach the documents above, select CiteLLM, and paste this request. Needs CiteLLM Pro.

More Check demos

Other documents, same check.